Search This Blog

Thursday, November 7, 2019

Corbus Pharmaceuticals EPS beats by $0.05, beats on revenue

Corbus Pharmaceuticals (NASDAQ:CRBP): Q3 GAAP EPS of -$0.32 beats by $0.05.
Revenue of $2.59M (+137.6% Y/Y) beats by $0.75M.
Shares +4% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)